feed,title,long_url,short_url
SeekingAlpha,WESCO misses top-line and bottom-line estimates; initiates FY24 outlook,https://seekingalpha.com/news/4065918,
SeekingAlpha,"Vertex, CRISPR gene therapy approved in EU for sickle cell disease, beta-thalassemia",https://seekingalpha.com/news/4065917,
SeekingAlpha,Organigram Holdings reports Q1 results,https://seekingalpha.com/news/4065916,
SeekingAlpha,"Leidos Non-GAAP EPS of $1.99 beats by $0.24, revenue of $4B beats by $190M",https://seekingalpha.com/news/4065914,
